X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2834) 2834
Book Review (728) 728
Publication (323) 323
Book Chapter (61) 61
Conference Proceeding (18) 18
Book / eBook (5) 5
Magazine Article (4) 4
Dissertation (2) 2
Reference (2) 2
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2333) 2333
humans (1661) 1661
aptamers, nucleotide - chemistry (846) 846
aptamer (816) 816
aptamers (813) 813
animals (782) 782
biochemistry & molecular biology (603) 603
ligands (598) 598
aptamers, nucleotide - therapeutic use (588) 588
dna (490) 490
cancer (468) 468
proteins (460) 460
aptamers, nucleotide - metabolism (408) 408
rna (403) 403
base sequence (386) 386
in-vitro selection (384) 384
deoxyribonucleic acid--dna (362) 362
selex (341) 341
selex aptamer technique (337) 337
nanoparticles (330) 330
chemistry, analytical (325) 325
aptamers, nucleotide - genetics (320) 320
binding (317) 317
article (313) 313
cell line, tumor (303) 303
selection (300) 300
protein binding (299) 299
analysis (297) 297
female (295) 295
biotechnology & applied microbiology (289) 289
medicine, research & experimental (272) 272
mice (272) 272
aptamers, nucleotide - pharmacology (270) 270
pharmacology & pharmacy (263) 263
male (258) 258
nucleic acid conformation (241) 241
protein (238) 238
nucleic acids (231) 231
vascular endothelial growth factor a - antagonists & inhibitors (231) 231
multidisciplinary sciences (225) 225
drug delivery systems (224) 224
research (224) 224
biophysics (214) 214
molecular sequence data (212) 212
rna aptamers (211) 211
cells (204) 204
in-vivo (200) 200
nanoscience & nanotechnology (198) 198
fluorescence (197) 197
ribonucleic acid--rna (196) 196
chemistry, multidisciplinary (195) 195
dna aptamers (194) 194
oligonucleotides (193) 193
ranibizumab (192) 192
systematic evolution (191) 191
aptamers, nucleotide - administration & dosage (189) 189
antibodies (188) 188
molecules (188) 188
therapy (187) 187
medicine (184) 184
health aspects (183) 183
affinity (181) 181
binding sites (178) 178
chemistry (175) 175
biochemical research methods (174) 174
molecular biology (174) 174
biosensors (171) 171
ophthalmology (170) 170
chemistry, medicinal (168) 168
in-vitro (166) 166
thrombin (165) 165
endothelial growth-factor (164) 164
biochemistry (160) 160
exponential enrichment (160) 160
macular degeneration (160) 160
therapeutics (160) 160
selex aptamer technique - methods (159) 159
deoxyribonucleic acid (158) 158
macular degeneration - drug therapy (158) 158
drugs (157) 157
research article (157) 157
review (156) 156
angiogenesis inhibitors - therapeutic use (154) 154
bevacizumab (154) 154
biotechnology (152) 152
nanotechnology (151) 151
recognition (150) 150
biosensor (149) 149
biology (148) 148
dna aptamer (145) 145
science (142) 142
tumors (141) 141
electrochemistry (139) 139
treatment outcome (138) 138
expression (137) 137
cell biology (135) 135
rna aptamer (135) 135
gene expression (134) 134
drug-delivery (133) 133
physiological aspects (133) 133
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2827) 2827
Japanese (17) 17
German (12) 12
Spanish (8) 8
French (7) 7
Polish (6) 6
Chinese (4) 4
Czech (3) 3
Danish (2) 2
Portuguese (2) 2
Russian (2) 2
Dutch (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, pp. CD007419 - CD007419
Background Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti-vascular endothelial growth factor... 
CLINICAL-TRIAL | RANIBIZUMAB PLUS PROMPT | RANDOMIZED CONTROLLED-TRIAL | Receptors, Vascular Endothelial Growth Factor [therapeutic use] | DEFERRED LASER | MEDICINE, GENERAL & INTERNAL | PEGAPTANIB SODIUM | Bevacizumab [adverse effects; therapeutic use] | Laser Coagulation [methods] | Aptamers, Nucleotide [adverse effects; therapeutic use] | Network Meta-Analysis | QUALITY-OF-LIFE | Macular Edema [drug therapy; etiology; surgery] | Vascular Endothelial Growth Factor A [antagonists & inhibitors] | Visual Acuity [drug effects; physiology] | COST-EFFECTIVENESS | Angiogenesis Inhibitors [adverse effects; therapeutic use] | LASER PHOTOCOAGULATION | Randomized Controlled Trials as Topic | Ranibizumab [adverse effects; therapeutic use] | Recombinant Fusion Proteins [adverse effects; therapeutic use] | Quality of Life | INTRAVITREAL BEVACIZUMAB | Diabetic Retinopathy [complications] | Triamcinolone [adverse effects; therapeutic use] | VEGF TRAP-EYE | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - adverse effects | Bevacizumab - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Ranibizumab - adverse effects | Visual Acuity - drug effects | Triamcinolone - adverse effects | Laser Coagulation - methods | Angiogenesis Inhibitors - therapeutic use | Angiogenesis Inhibitors - adverse effects | Triamcinolone - therapeutic use | Visual Acuity - physiology | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - adverse effects | Macular Edema - surgery | Macular Edema - drug therapy | Index Medicus
Journal Article
ChemBioChem, ISSN 1439-4227, 03/2009, Volume 10, Issue 5, pp. 862 - 868
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2008, Volume 105, Issue 45, pp. 17356 - 17361
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2006, Volume 103, Issue 16, pp. 6315 - 6320
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 07/2015, Volume 209, pp. 88 - 100
Targeted, disease-specific delivery of therapeutic nanoparticles shows wonderful promise for transmitting highly cytotoxic anti-cancer agents. Using the... 
Epithelial cell adhesion molecule | Nanopolymersome | PEG–PLGA | Doxorubicin | SK-MES-1 | Non-small cell lung cancer | PEG-PLGA | EFFICACY | ADENOCARCINOMA | EPCAM EXPRESSION | MONOCLONAL-ANTIBODY | TUMOR-CELLS | ANTITUMOR-ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | NANOPARTICLES | EP-CAM | PHARMACOLOGY & PHARMACY | DRUG-DELIVERY SYSTEMS | Hemolysis - drug effects | Doxorubicin - therapeutic use | Lung Neoplasms - drug therapy | Cell Adhesion Molecules - genetics | Nanoparticles - chemistry | Humans | Lung Neoplasms - pathology | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Doxorubicin - chemistry | Antineoplastic Agents - administration & dosage | Aptamers, Nucleotide - administration & dosage | Pyrimidines - chemistry | Epithelial Cell Adhesion Molecule | Nanoparticles - therapeutic use | Polyglactin 910 - chemistry | Doxorubicin - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Antigens, Neoplasm - genetics | Aptamers, Nucleotide - chemistry | Aptamers, Nucleotide - therapeutic use | Antineoplastic Agents - chemistry | Erythrocytes - drug effects | Tumor Burden - drug effects | Cell Line, Tumor | Heart - drug effects | Nanoparticles - administration & dosage | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung cancer, Non-small cell | Lung cancer, Small cell | Analysis | Drugs | Anthracyclines | Drug delivery systems | Vehicles | Index Medicus
Journal Article
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, ISSN 1469-493X, 2019, Volume 3, Issue 3, pp. CD005139 - CD005139
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 09/2016, Volume 238, pp. 43 - 57
Journal Article
Biomaterials, ISSN 0142-9612, 2010, Volume 31, Issue 16, pp. 4592 - 4599
Journal Article